Knockdown of CLDN6 significantly inhibited cell proliferation and the colony numbers of human endometrial adenocarcinoma cells via remarkable reduction of p-AKT, p-PI3K, and mTOR expression levels [20]. The gene discussed is CLDN6; the disease is endometrium adenocarcinoma.